Cargando…
Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease
BACKGROUND: Paraoxonase-1 (PON1) is an antioxidant enzyme synthesized by the liver. It protects against liver impairment and attenuates the production of the pro-inflammatory monocyte chemoattractant protein-1 (MCP-1). We investigated the relationships between hepatic PON1 and MCP-1 expression in ra...
Autores principales: | Marsillach, Judit, Camps, Jordi, Ferré, Natàlia, Beltran, Raul, Rull, Anna, Mackness, Bharti, Mackness, Michael, Joven, Jorge |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2632645/ https://www.ncbi.nlm.nih.gov/pubmed/19144177 http://dx.doi.org/10.1186/1471-230X-9-3 |
Ejemplares similares
-
Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment
por: Marsillach, Judit, et al.
Publicado: (2010) -
Paraoxonase-1 and -3 Protein Expression in the Brain of the Tg2576 Mouse Model of Alzheimer’s Disease
por: Salazar, Jose Gregorio, et al.
Publicado: (2021) -
Paraoxonase-1 Inhibits Oxidized Low-Density Lipoprotein-Induced Metabolic Alterations and Apoptosis in Endothelial Cells: A Nondirected Metabolomic Study
por: García-Heredia, Anabel, et al.
Publicado: (2013) -
PPARs in Regulation of Paraoxonases: Control of Oxidative Stress and Inflammation Pathways
por: Camps, Jordi, et al.
Publicado: (2012) -
Methodological constraints in interpreting serum paraoxonase-1 activity measurements: an example from a study in HIV-infected patients
por: Parra, Sandra, et al.
Publicado: (2010)